Frequently Asked Questions (FAQ)
1. What is MATIMOP?
MATIMOP - the Israeli Industry Center for R&D - is a national agency in charge of promoting industrial R&D cooperation and innovation, on behalf of the Office of the Chief Scientist in the Ministry of Industry, Trade and Labor in Israel. It promotes joint industrial development of advanced technologies and maintains an updated database of profiles of Israeli industrial companies seeking international cooperation.
In the international arena, MATIMOP promotes and assists the participation of Israeli companies in international bilateral or multilateral cooperation programs for industrial R&D with foreign entities both at the governmental and corporate levels.
This is expressed by means of the following approaches:
- Joint industrial R&D support foundations with the United States, Canada, South Korea and Singapore.
- R&D cooperation programs with multi-national corporations such as Deutsche Telekom, IBM, Microsoft, Merck etc.
- Active participation in the major EU R&D programs such as EUREKA and Fp7.
- Numerous bilateral agreements between government R&D funding bodies in Israel and the partner country.
Indeed, MATIMOP is the national contact point for most of the bi-lateral industrial R&D programs.
2. Who is eligible to apply?
The bi-national programs are open to all industrial/commercial companies performing R&D, from start-ups to multi-nationals. Academic and research institutions, hospitals, and other non-profit entities may participate as sub-contractors.
Please note that the criteria to be followed in order to apply to the program call are:
a) At least two science and technology companies from the respective countries should express a desire to cooperate in the research and development of a new and technologically innovative product or process.
b) Furthermore, the project may involve more than one company from each side; academic /research entities are eligible to join as sub-contractors only.
c) At last, the project partners should agree in advance on the IP rights and on the commercialization strategy of the product or process.
3. What types of projects are eligible to receive funding?
The bi-national programs support commercially-focused R&D projects between Israeli companies and foreign companies in all fields of technology, although the coordinating authorities may choose to emphasize or offer a preference to one or more technology field. The product/process/application should be highly innovative with significant commercial potential. The joint industrial R&D project should aim at development of products/processes leading to commercialization in the global market
4. I have a project idea, but no partner. What do I do?
MATIMOP will assist companies on a regular basis to find potential partners. This includes foreign companies looking for Israeli partners, and Israeli companies looking for foreign partners. You should contact the relevant MATIMOP Program Manager, or visit the webpage, based on which framework or region you want to find a partner in (Asia, Europe, North America, or South America). Then you must fill out a Partner Search Form in order to begin the matchmaking process.
Please note that a bottom-up approach is emphasized here: indeed, project concepts are initiated by the companies themselves.
5. How are projects evaluated?
Projects are evaluated on the basis of technological, commercial and financial parameters. In Israel, the professional evaluation is conducted by OCS reviewers according to rigorous standards long practiced by the OCS. A parallel process takes place in the partner country. Projects are rated, ranked and submitted to the Coordinating Committee for review, comparison and approval. From the time of application until a decision is made typically takes about three months.
6. How much funding can I receive?
Grants to the partner companies are given up to 50% of the approved R&D project expenses plus regional incentives. Whether the grant is "conditional", i.e. that it must be repaid if the project results in actual commercial sales, is determined in accordance with the regulations of each country. As for Israeli companies, royalty payments of 3% - 5% of sales are required.